MedTrace Logo

Does Transcranial Magnetic Stimulation of the Cingulate Cortex Modulate the Perception of Dyspnoea?

NCT00830921 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2012-06-18

No results posted yet for this study

Summary

The treatment we are studying is Transcranial Magnetic Stimulation (TMS). In TMS, an electromagnetic pulse is passed into the brain through a coil placed on the head. Previous studies have shown TMS to be capable of altering brain activity in specific areas; for example it has been used to improve mood in clinical depression. In this study we will assess if, by targeting TMS to the brain area responsible for feeling breathless, participants' breathlessness will be improved

Conditions

  • Malignancy

Interventions

DEVICE

Transcranial Magnetic Stimulation

Transcranial magnetic stimulation (TMS) is a non-invasive method for altering brain activity in vivo.

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Principal Investigators

  • Robert Davies · Oxford Centre For Respiratory Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Completion
2012-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00830921 on ClinicalTrials.gov